Registered after rigorous testing by the US EPA
Antimicrobial Copper is the only class of solid touch surfaces registered by the US EPA to continuously kill bacteria* that cause infections and pose a risk to human health.
After many years of independent laboratory testing, followed by
additional rigorous testing under US Environmental Protection
Agency (EPA) approved protocols, 275 copper alloys (including brass
and bronze) were registered as public health antimicrobial products
by U.S. EPA on February 29, 2008. The number of registered alloys
has since been increased to 282. Public health products are
intended to control microorganisms associated with infections or
other adverse effects in humans.
Silver-containing coatings do not have public health
registration from EPA. These products are marketed under a
"Treated Article Exemption" which means the antimicrobial additive
only may protect the product itself from degradation and odor
caused by non-specific organisms.
Silver-containing coatings do not continuously kill bacteria
that cause infections. Antimicrobial Copper surfaces do.
Official U.S. EPA Announcement of the Registration of Antimicrobial
Copper Alloys
Antimicrobial Copper alloy products can claim to kill 99.9% of
disease causing bacteria* within two hours, when
cleaned regularly and as a supplement to routine cleaning and
disinfection programmes.
EPA registration is a legal U.S. federal government decision
acknowledging the efficacy of Antimicrobial Copper products against
the 6 following disease-causing bacteria:
- E. coli O157:H7, a food-borne pathogen that has been
associated with large-scale food recalls;
- Methicillin-Resistant Staphylococcus aureus (MRSA),
one of the most virulent strains of antibiotic-resistant bacteria
and a common culprit of hospital- and community-acquired
infections;
- Staphylococcus aureus, the most common of all
bacterial staphylococcus (i.e. staph) infections that can cause
life-threatening diseases, including pneumonia and meningitis;
- Vancomycin-Resistant Enterococcus faecalis (VRE), an
antibiotic resistant organism responsible for 4% of all
Healthcare-Associated Infection;
- Enterobacter aerogenes, a pathogenic bacterium
commonly found in hospitals that causes opportunistic skin
infections and impacts other body tissues; and,
- Pseudomonas aeruginosa, a bacterium that infects the
pulmonary tracts, urinary tracts, blood, and skin of
immunocompromised individuals.
Unlike traditional antimicrobial products marketed with public
health claims-typically gases, liquids, sprays, and concentrated
powders-Antimicrobial Copper alloys are solid surface
materials.
In the US, Antimicrobial Copper products can only be sold by
registered manufacturers using registered copper alloys.
To view the registered public health claims, visit: Public Health
Claims.
For further information, visit the US section of his
website.
*Peer reviewed scientific publications show Antimicrobial Copper
to be effective against bacteria, viruses, fungi and moulds,
including MRSA, Influenza A (H1N1), Clostridium difficile
and VRE.
Antimicrobial Copper is the only touch surface material to have
efficacy data independently verified through the US Environmental
Protection Agency (EPA) registration which supports the claim to
continuously kill more than 99.9% of the bacteria that cause HCAIs
within two hours of contact. Organisms tested are MRSA,
Staphylococcus aureus, Enterobacter aerogenes,
Pseudomonas aeruginosa, E. coli O157:H7 and
Vancomycin-resistant Enterococcus faecalis.
Further work1 has demonstrated that Antimicrobial
Copper outperforms two commercially available silver-containing
coatings under typical indoor conditions.
A study2 on a busy medical ward at Selly Oak Hospital
showed a 90-100% reduction in contamination on Antimicrobial Copper
surfaces compared to surfaces made of conventional materials.
Trials in the US and Chile confirm these results. Antimicrobial
Copper surfaces are a supplement to, and not a substitute for,
standard infection control practices and have been shown to reduce
microbial contamination.
[1] Effects of temperature and humidity on the
efficacy of methicillin-resistant Staphylococcus aureus
challenged antimicrobial materials containing silver and
copper. H T Michels, J O Noyce and C W Keevil, Letters in
Applied Microbiology, 49 (2009) 191-195.
[2]
Role of copper in reducing hospital environment contamination.
A L Casey, D Adams, T J Karpanen, P A Lambert, B D Cookson, P
Nightingale, L Miruszenko, R Shillam, P Christian and T S J
Elliott, J Hosp Infect (2009).